Shari Goldfarb
Dr. Shari Goldfarb is a breast oncologist who has expressed concerns regarding hormone replacement therapy (HRT) and its safety for patients, particularly those at risk for breast cancer. She emphasizes the need for careful consideration and discussions about the risks associated with HRT, especially in patients with a history of hormone-sensitive cancers.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Turkey | 1 | 4.00 | 0.09% | +0% | 84,339,067 | 74,112 | $720,000 | 633$ |
| Totals | 1 | 84,339,067 | 74,112 | $720,000 | 633$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Turkey:
Dr. Shari Goldfarb expressed concern that hormone therapy may not be safe for her patients.
4